Evofem Biosciences, Inc.EVFMOTCMARKET
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank83
5Y CAGR+12.2%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+12.2%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 56.99% |
| 2023 | 78.78% |
| 2022 | 49.57% |
| 2021 | -60.97% |
| 2020 | -96.47% |
| 2019 | 32.07% |
| 2018 | -117.56% |
| 2017 | -196.35% |
| 2016 | 71.36% |
| 2015 | -338.42% |